Dexmedetomidine can attenuate the activity of the sympathetic nervous system under stress response and improve ischemia-reperfusion injury. The investigators hypothesized that the prolonged sedation of dexmedetomidine after successful reperfusion of endovascular thrombectomy may improve the clinical outcome of acute ischemic stroke patients.
Endovascular treatment with mechanical thrombectomy is the standard treatment for acute large vessel occlusion. Dexmedetomidine is a commonly used sedative in endovascular thrombectomy of acute ischemic stroke. Dexmedetomidine can attenuate the activity of the sympathetic nervous system under stress response and improve ischemia-reperfusion injury. The investigators hypothesized that the prolonged sedation of dexmedetomidine after successful reperfusion of endovascular thrombectomy may improve the clinical outcome of acute ischemic stroke patients.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
368
Dexmedetomidine for 24h after patients finished endovascular thrombectomy and returned to ICU.
An equal dose of 0.9% saline 24h after patients finished endovascular thrombectomy and returned to ICU.
Beijing ChaoYang Hospital
Beijing, Beijing Municipality, China
RECRUITINGThe favorable functional outcome of stroke-related disability rate
Modified Rankin Scale ≤ 2 points. mRS range from 0 to 6, higher scores mean a worse outcome.
Time frame: 90 ± 14 days after thrombectomy
Changes of National Institute of Health stroke scale
NIHSS (admission) - NIHSS (24h)
Time frame: 24 ± 6 hours after thrombectomy
Changes of National Institute of Health stroke scale
NIHSS (admission) - NIHSS (7day)
Time frame: on the 7-day or discharged day whichever comes first, up to 30 days
Changes of ischemic penumbra
The difference of infarct volume between preoperative and 7-day or discharged day
Time frame: on the 7-day or discharged day whichever comes first, up to 30 days
Length of ICU stay
Length of ICU stay
Time frame: From the date of admission until discharged from ICU, up to 30 days
Length of hospital stay
Length of hospital stay
Time frame: From the date of admission until discharged from hospital, up to 30 days
adverse events at 90-day after operation
hypotension (systolic blood pressure under 90mmHg), bradycardia (heart rate under 50bpm), hypoxemia (pulse oxygen saturation under 90%), and serious events such as death and life-threatening events
Time frame: within 90-day after thrombectomy
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
mortality rate at 90-day after operation
Death after thrombectomy within 90-day after operation
Time frame: within 90-day after thrombectomy